The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Niclosamide: Beyond an antihelminthic drug
Open accessAbstract
Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide. However recent studies have indicated that niclosamide may have broad clinical applications for the treatment of diseases other than those caused by parasites. These diseases and symptoms may include cancer, bacterial and viral infection, metabolic diseases such as Type II diabetes, NASH and NAFLD, artery constriction, endometriosis, neuropathic pain, rheumatoid arthritis, sclerodermatous graft-versus-host disease, systemic sclerosis. Among the underlying mechanisms associated with the drug actions of niclosamide are uncoupling of oxidative phosphorylation, and modulation of Wnt/β-catenin, mTORC1, STAT3, NF-κB and Notch signaling pathways. Here we provide a brief overview of the biological activities of niclosamide, its potential clinical applications, and its challenges for use as a new therapy for systemic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedOstrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P. A., Arora, V., Wongvipat, J., Smith-Jones, P. M., Yoo, D., Kwon, A., et al. (2009) · Science · doi:10.1126/science.1168175 · Cited by 2,292
The Epidemiology of Osteosarcoma
Ottaviani, G., & Jaffe, N. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_1 · Cited by 1,786
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
The biology and future prospects of antivirulence therapies
Cegelski, L., Marshall, G. R., Eldridge, G. R., & Hultgren, S. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1818 · Cited by 788
Mining the Wnt pathway for cancer therapeutics
Barker, N., & Clevers, H. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2154 · Cited by 743
Chikungunya Fever: An Epidemiological Review of a Re‐Emerging Infectious Disease
Staples, J. E., Breiman, R. F., & Powers, A. M. (2009) · Clinical Infectious Diseases · doi:10.1086/605496 · Cited by 735
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
Xu, M., Lee, E. M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., TCW, J., Kouznetsova, J., Ogden, S. C., Hammack, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4184 · Cited by 641
Mechanisms of resistance in castration-resistant prostate cancer (CRPC).
Chandrasekar, T., Yang, J. C., Gao, A. C., & Evans, C. P. (2015) · PubMed · doi:10.3978/j.issn.2223-4683.2015.05.02 · Cited by 514
Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?
Kebebew, E., Reiff, E., Duh, Q., Clark, O. H., & McMillan, A. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0329-x · Cited by 451
Zika virus and microcephaly: why is this situation a PHEIC?
Heymann, D. L., Hodgson, A., Sall, A. A., Freedman, D. O., Staples, J. E., Althabe, F., Baruah, K., Mahmud, G., Kandun, N., Vasconcelos, P. F. C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00320-2 · Cited by 415
Pathogenesis of Systemic Sclerosis
Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00272 · Cited by 405
Liu, C., Lou, W., Zhu, Y., Nadiminty, N., Schwartz, C. T., Evans, C. P., & Gao, A. C. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3296 · Cited by 348
The biology and toxicology of molluscicides, bayluscide
Andrews, P., Thyssen, J., & Lorke, D. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90064-x · Cited by 347
Tuberculosis: A disease without boundaries
Fogel, N. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.05.017 · Cited by 328
Jin, Y., Lu, Z., Ding, K., Li, J., Du, X., Chen, C., Sun, X., Wu, Y., Zhou, J., & Pan, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3950 · Cited by 322
Triple negative breast cancer: unmet medical needs
Pal, S. K., Childs, B. H., & Pegram, M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1293-1 · Cited by 322
Kim, S.-Y., Kang, J. W., Song, X., Kim, B. K., Yoo, Y. D., Kwon, Y. T., & Lee, Y. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.007 · Cited by 297
Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
Tao, H., Zhang, Y., Zeng, X., Shulman, G. I., & Jin, S. (2014) · Nature Medicine · doi:10.1038/nm.3699 · Cited by 288
Fasciolicides: Efficacy, Actions, Resistance and its Management
FAIRWEATHER, I., & BORAY, J. C. (1999) · The Veterinary Journal · doi:10.1053/tvjl.1999.0377 · Cited by 280
Osada, T., Chen, M., Yang, X. Y., Spasojevic, I., Vandeusen, J. B., Hsu, D., Clary, B. M., Clay, T. M., Chen, W., Morse, M. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3978 · Cited by 271
Self-citationMechanism of Action of Reagents that uncouple Oxidative Phosphorylation
WEINBACH, E. C., & GARBUS, J. (1969) · Nature · doi:10.1038/2211016a0 · Cited by 263
Breast cancer statistics and markers
Kondapalli, K., Donepudi, M., Amos, S. J., & Venkanteshan, P. (2014) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.137927 · Cited by 252
Type 2 diabetes: A 21st century epidemic
Jaacks, L. M., Siegel, K. R., Gujral, U. P., & Narayan, K. M. V. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.05.003 · Cited by 248
Current progress in antiviral strategies
Lou, Z., Sun, Y., & Rao, Z. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.11.006 · Cited by 244
Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide
Wu, C.-J., Jan, J.-T., Chen, C.-M., Hsieh, H.-P., Hwang, D.-R., Liu, H.-W., Liu, C.-Y., Huang, H.-W., Chen, S.-C., Hong, C.-F., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2693-2696.2004 · Cited by 240
Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
Ren, X., Duan, L., He, Q., Zhang, Z., Zhou, Y., Wu, D., Pan, J., Pei, D., & Ding, K. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100146z · Cited by 234
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Jurgeit, A., McDowell, R., Moese, S., Meldrum, E., Schwendener, R., & Greber, U. F. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002976 · Cited by 231
Lu, W., Lin, C., Roberts, M. J., Waud, W. R., Piazza, G. A., & Li, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029290 · Cited by 230
The selection and use of essential medicines.
Kazembe, P. N., Fannah, J. A., Hoppu, K., Zisovska, E., Pedersen, H., Hill, S., Ondari, C. O., Terlouw, D. J., Mattison, D. R., Zhi-ping, L., et al. (2004) · PubMed · Cited by 215
WNT signaling underlies the pathogenesis of neuropathic pain in rodents
Zhang, Y.-K., Huang, Z.-J., Liu, S., Liu, Y.-P., Song, A. A., & Song, X.-J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65364 · Cited by 214
The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
Chen, M., Wang, J., Lu, J., Bond, M. C., Ren, X.-R., Lyerly, H. K., Barak, L. S., & Chen, W. (2009) · Biochemistry · doi:10.1021/bi9009677 · Cited by 213
Self-citationNovel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
Sack, U., Walther, W., Scudiero, D., Selby, M., Kobelt, D., Lemm, M., Fichtner, I., Schlag, P. M., Shoemaker, R. H., & Stein, U. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr190 · Cited by 212
Wnt–Notch signalling crosstalk in development and disease
Collu, G. M., Hidalgo-Sastre, A., & Brennan, K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1644-x · Cited by 198
Imperi, F., Massai, F., Ramachandran Pillai, C., Longo, F., Zennaro, E., Rampioni, G., Visca, P., & Leoni, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01952-12 · Cited by 197
Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
You, S., Li, R., Park, D., Xie, M., Sica, G. L., Cao, Y., Xiao, Z.-Q., & Deng, X. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0608 · Cited by 182
Endocrine disrupting chemicals and endometriosis
Smarr, M. M., Kannan, K., & Louis, G. M. B. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.06.034 · Cited by 176
Developmental pathways in colon cancer: Crosstalk between WNT, BMP, Hedgehog and Notch
Bertrand, F. E., Angus, C. W., Partis, W. J., & Sigounas, G. (2012) · Cell Cycle · doi:10.4161/cc.22134 · Cited by 173
Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision
Nakamura, T., Tsuchiya, K., & Watanabe, M. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2087-z · Cited by 171
Anticancer Effects of Niclosamide in Human Glioblastoma
Wieland, A., Trageser, D., Gogolok, S., Reinartz, R., Höfer, H., Keller, M., Leinhaas, A., Schelle, R., Normann, S., Klaas, L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2895 · Cited by 168
Li, R., Hu, Z., Sun, S., Chen, Z. G., Owonikoko, T. K., Sica, G., Ramalingam, S. S., Curran, W. J., Khuri, F. R., & Deng, X. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0095 · Cited by 167
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
Arend, R. C., Londoño-Joshi, A. I., Samant, R. S., Li, Y., Conner, M., Hidalgo, B., Alvarez, R. D., Landen, C. N., Straughn, J. M., & Buchsbaum, D. J. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.04.005 · Cited by 161
Benfield, T., Espersen, F., Frimodt-Møller, N., Jensen, A. G., Larsen, A. R., Pallesen, L. V., Skov, R., Westh, H., & Skinhøj, P. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01589.x · Cited by 161
Fonseca, B. D., Diering, G. H., Bidinosti, M. A., Dalal, K., Alain, T., Balgi, A. D., Forestieri, R., Nodwell, M., Rajadurai, C. V., Gunaratnam, C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359638 · Cited by 159
Hu, C.-D., Choo, R., & Huang, J. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00090 · Cited by 159
Niclosamide Therapy for Tapeworm Infections
PEARSON, R. D., & HEWLETT, E. L. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-4-550 · Cited by 152
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
Rajamuthiah, R., Fuchs, B. B., Conery, A. L., Kim, W., Jayamani, E., Kwon, B., Ausubel, F. M., & Mylonakis, E. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124595 · Cited by 150
Salicylanilides: A New Group of Active Uncouplers of Oxidative Phosphorylation
Williamson, R. L., & Metcalf, R. L. (1967) · Science · doi:10.1126/science.158.3809.1694 · Cited by 149
Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
Wang, Y.-C., Chao, T., Chang, C., Yo, Y.-T., Yu, M.-H., & Lai, H.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074538 · Cited by 132
Swan, G. E. (1999) · Journal of the South African Veterinary Association · doi:10.4102/jsava.v70i2.756 · Cited by 131
Gerhardt, K. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.142240 · Cited by 126
The role of the Hes1 crosstalk hub in Notch-Wnt interactions of the intestinal crypt
Kay, S. K., Harrington, H. A., Shepherd, S., Brennan, K. R., Dale, T. C., Osborne, J. M., Gavaghan, D. J., & Byrne, H. M. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005400 · Cited by 124
The mechanisms of action of antiprotozoal and anthelmintic drugs in man
Frayha, G. J., Smyth, J. D., Gobert, J. G., & Savel, J. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00149-8 · Cited by 123
Growth Inhibition of Ovarian Tumor–Initiating Cells by Niclosamide
Yo, Y.-T., Lin, Y.-W., Wang, Y.-C., Balch, C., Huang, R., Chan, M. W. Y., Sytwu, H., Chen, C.-K., Chang, C., Nephew, K. P., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0002 · Cited by 122
The Ins and Outs of Anthrax Toxin
Friebe, S., der Goot, F. V., & Bürgi, J. (2016) · Toxins · doi:10.3390/toxins8030069 · Cited by 118
Liu, C., Lou, W., Armstrong, C. M., Zhu, Y., Evans, C. P., & Gao, A. C. (2015) · The Prostate · doi:10.1002/pros.23015 · Cited by 114
Wang, Y., Lu, J., Lin, C.-C., Chin, Y., Wu, T., Lin, L., Lai, Z.-Z., Kuo, S.-C., & Ho, Y. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.10.003 · Cited by 113
de Carvalho, L. P. S., Darby, C. M., Rhee, K. Y., & Nathan, C. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200157f · Cited by 111
Bone Metastasis from Renal Cell Carcinoma
Chen, S., & Kuo, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060987 · Cited by 107
Wang, A., Ku, H., Liang, Y., Chen, Y., Hwu, Y., & Yeh, T. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22065 · Cited by 104
Selection and Use of Essential Medicines
Moja, L., & Huttner, B. D. (2023) · Sustainable development goals series · doi:10.1007/978-3-031-33851-9_49 · Cited by 104
Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma
Satoh, K., Zhang, L., Zhang, Y., Chelluri, R. R., Boufraqech, M., Nilubol, N., Patel, D., Shen, M., & Kebebew, E. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2256 · Cited by 101
Effect of Niclosamide on Basal-like Breast Cancers
Londoño-Joshi, A. I., Arend, R. C., Aristizabal, L., Lu, W., Samant, R. S., Metge, B. J., Hidalgo, B., Grizzle, W. E., Conner, M., Forero-Torres, A., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0555 · Cited by 97
Fragoso, M. A., Patel, A. K., Nakamura, R. E. I., Yi, H., Surapaneni, K. R., & Hackam, A. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046892 · Cited by 97
Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
Li, R. Q., You, S., Hu, Z., Chen, Z. G., Sica, G., Khuri, F. R., Curran, W. J., Shin, D. M., & Deng, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074670 · Cited by 93
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer
King, M., Lindberg, M. E., Stodden, G. R., Okuda, H., Ebers, S., Johnson, A., MONTAG, A. G., Lengyel, E. R., MacLean, J. A., & Hayashi, K. (2014) · Oncogene · doi:10.1038/onc.2014.277 · Cited by 91
Suliman, M. A., Zhang, Z., Na, H., Ribeiro, A. L. L., Zhang, Y., Niang, B., Hamid, A. S., Zhang, H., Xu, L., & Zuo, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2689 · Cited by 89
Crona, D. J., Milowsky, M., & Whang, Y. E. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.256 · Cited by 87
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
Lin, C.-K., Bai, M.-Y., Hu, T., Wang, Y.-C., Chao, T., Weng, S.-J., Huang, R., Su, P., & Lai, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7113 · Cited by 86
Liao, Z., Nan, G., Yan, Z., Zeng, L., Deng, Y., Ye, J., Zhang, Z., Qiao, M., Li, R., Denduluri, S. K., et al. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009615666150629132157 · Cited by 84
Self-citationGlioma an overview of current classifications characteristics molecular biology and target therapies
Gao, L. (2015) · Frontiers in bioscience · doi:10.2741/4362 · Cited by 82
The Notch pathway in the developing hematopoietic system
Bigas, A., Robert‐Moreno, A., & Espinosa, L. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.093049ab · Cited by 80
Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique
Ye, Y., Zhang, X., Zhang, T., Wang, H., & Wu, B. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.954585 · Cited by 78
Piccaro, G., Giannoni, F., Filippini, P., Mustazzolu, A., & Fattorini, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02154-12 · Cited by 73
Mook, R. A., Wang, J., Ren, X.-R., Chen, M., Spasojević, I., Barak, L. S., Lyerly, H. K., & Chen, W. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.001 · Cited by 68
Self-citationPharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats
Chang, Y., Yeh, T., Lin, K.-T., et al. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.2464 · Cited by 67
Jin, B., Wang, C., Li, J., Du, X., Ding, K., & Pan, J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0226 · Cited by 66
Liu, J., Chen, X., Ward, T. M., Pegram, M. D., & Shen, K. (2016) · Tumor Biology · doi:10.1007/s13277-015-4650-1 · Cited by 63
Hassanian, S. M., Ardeshirylajimi, A., Dinarvand, P., & Rezaie, A. R. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13477 · Cited by 57
Yin, L., Gao, Y. L., Zhang, X., Wang, J., Ding, D., Zhang, Y., Zhang, J., & Chen, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9704 · Cited by 54
Self-citationNovel targets in the treatment of chronic graft-versus-host disease
Im, A., Hakim, F. T., & Pavletic, S. Z. (2016) · Leukemia · doi:10.1038/leu.2016.367 · Cited by 54
Liang, L., Huang, M., Xiao, Y., Zen, S., Lao, M., Zou, Y., Shi, M., Yang, X., & Xu, H. (2015) · Inflammation Research · doi:10.1007/s00011-015-0801-5 · Cited by 52
Niclosamide enhances ROS-mediated cell death through c-Jun activation
Lee, S., Son, A.-R., Ahn, J., & Song, J. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.03.018 · Cited by 49
Prather, G. R., MacLean, J. A., Shi, M., Boadu, D., Paquet, M., & Hayashi, K. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.140236 · Cited by 47
Karakaş, D., Cevatemre, B., Aztopal, N., Arı, F., Yılmaz, V. T., & Ulukaya, E. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.026 · Cited by 44
Ippolito, J. E., Brandenburg, M. W., Ge, X., Crowley, J. R., Kirmess, K. M., Som, A., d’Avignon, D. A., Arbeit, J. M., Achilefu, S., Yarasheski, K. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159675 · Cited by 40
Zhao, J., He, Q., Gong, Z., Chen, S., & Cui, L. (2016) · SpringerPlus · doi:10.1186/s40064-016-3153-x · Cited by 40
Niclosamide ethanolamine inhibits artery constriction
Li, S., Yan, J., Zhang, Y., Zhen, C., Liu, M., Jin, J., Gao, J., Xiao, X., Shen, X., Tai, Y., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.008 · Cited by 40
In vitro trypanocidal activity of the anti-helminthic drug niclosamide
Merschjohann, K., & Steverding, D. (2008) · Experimental Parasitology · doi:10.1016/j.exppara.2007.12.001 · Cited by 39
Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species–Induced Mouse Model
Morin, F., Kavian, N., Nicco, C., Cerles, O., Chéreau, C., & Batteux, F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502482 · Cited by 39
Erlotinib in the treatment of non-small cell lung cancer: current status and future developments.
Gridelli, C., Maione, P., Bareschino, M. A., Schettino, C., Sacco, P. C., Ambrosio, R., Barbato, V., Falanga, M., & Rossi, A. (2010) · PubMed · Cited by 38
Jurgeit, A., Moese, S., Roulin, P., Dorsch, A. B., Lötzerich, M., Lee, W.-M., & Greber, U. (2010) · Virology Journal · doi:10.1186/1743-422x-7-264 · Cited by 37
Update on Therapeutic Approaches for Rheumatoid Arthritis
Nogueira, E., Gomes, A. C., Preto, A., & Cavaco-Paulo, A. M. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160506125218 · Cited by 34
Holmes, D. I. R. (2015) · Nature · doi:10.1038/521s2a · Cited by 33
Mechanosensitive G q/11 Protein–Coupled Receptors Mediate Myogenic Vasoconstriction
y Schnitzler, M. M., Storch, U., & Gudermann, T. W. (2016) · Microcirculation · doi:10.1111/micc.12293 · Cited by 33
Iacobino, A., Piccaro, G., Giannoni, F., Mustazzolu, A., & Fattorini, L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02296-16 · Cited by 31
Niclosamide Analogs for Treatment of Ovarian Cancer
Haygood, C. L. W., Arend, R. C., Gangrade, A., Chettiar, S. N., Regan, N., Hassmann, C. J., Li, P., Hidalgo, B., Straughn, J. M., & Buchsbaum, D. J. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000506 · Cited by 25
Mook, R. A., Ren, X.-R., Wang, J., Piao, H., Barak, L. S., Lyerly, H. K., & Chen, W. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.01.046 · Cited by 21
Self-citationAi, N., Wood, R. D., Yang, E., & Welsh, W. J. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2027-9 · Cited by 18
Nonalcoholic Fatty Liver Disease and Liver Transplantation
Pham, T. A., Dick, T. B., & Charlton, M. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.014 · Cited by 17
Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.
Morin, F., Kavian, N., Nicco, C., Cerles, O., Chéreau, C., & Batteux, F. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.624 · Cited by 16
Cited by
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
Xu, J., Shi, P.-Y., Li, H., & Zhou, J. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00052 · Cited by 340
Antibiotics in the clinical pipeline in October 2019
Butler, M. S., & Paterson, D. L. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0291-8 · Cited by 264
New drugs are not enough‑drug repositioning in oncology: An update
Armando, R., Mengual G�mez, D., & Gomez, D. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4966 · Cited by 90
A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities
Park, W.-J., & Kim, M. J. (2023) · Cells · doi:10.3390/cells12081110 · Cited by 57
Kaushal, J., Bhatia, R., Kanchan, R., Raut, P., Mallapragada, S., Ly, Q., Batra, S., & Rachagani, S. (2021) · Cancers · doi:10.3390/cancers13133105 · Cited by 35
Metadata
- Authors
- Chen, W., Mook, R. A., Premont, R. T., & Wang, J.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 41
- Pages
- 89-96
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2605112455
- Cited by
- 444
- References
- 105
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.